Skip to main content
Log in

Antinuclear Autoantibodies in Patients with Inflammatory Bowel Disease (High Prevalence in First-Degree Relatives)

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Crohn's disease and ulcerative colitis show afamilial aggregation. The role of antinuclearautoantibodies, which occur in both diseases, remains tobe defined. In 76 patients with Crohn's disease, 61patients with ulcerative colitis, 105 first-degreerelatives of patients with Crohn's disease, 101first-degree relatives of patients with ulcerativecolitis, and 40 healthy unrelated controls antinuclearautoantibodies were detected by indirect immunofluorescence.Existence of autoantibodies was correlated with clinicalfeatures. Eighteen percent of patients with Crohn'sdisease (14/76), 43% of patients with ulcerative colitis (26/61), 13% of relatives of patientswith Crohn's disease (14/105), 24% of relatives ofulcerative colitis patients (24/101), and 2% of thehealthy controls (1/40) were positive for antinuclear autoantibodies. The difference between controlsand patients and the first-degree relatives of patientswith ulcerative colitis, respectively, was statisticallysignificant (P ≤ 0.0144). In ulcerative colitis, the existence of antinuclear autoantibodies wasnegatively correlated with immunosuppressive therapy orextraintestinal manifestations (P = 0.0004 and 0.0273,respectively). Antinuclear autoantibodies may represent a factor disposing to the developmentof ulcerative colitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Zauli D, Crespi C, Dall Amore P, Bianchi FB, Pisi E: Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 32:140–144, 1985

    Google Scholar 

  2. Hibi T, Ohara M, Toda K, Hara A, Ogata H, Iwao Y, Watanabe N, Watanabe M, Hamada Y, Kobayashi K: In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis. Gut 31:1371–1376, 1990

    Google Scholar 

  3. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202–210, 1990

    Google Scholar 

  4. Seibold F, Weber P, Jenss H, Wiedmann KH: Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: Specific markers for a subgroup of patients with Crohn's disease. Gut 32:1192–1197, 1991

    Google Scholar 

  5. Stocker W, Otte M, Scriba PC: Immunopathogenesis of Crohn's disease. Dtsch Med Wochenschr 109:1984–1986, 1984

    Google Scholar 

  6. Podolsky DK: Inflammatory bowel disease (2). N Engl J Med 325:1008–1016, 1992

    Google Scholar 

  7. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100:1590–1596, 1991

    Google Scholar 

  8. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM: Soluble interleukin-2 receptors, antineutrophil cytoplasmatic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34:658–664, 1993

    Google Scholar 

  9. Reumaux D, Meziere C, Colombel JF, Duthilleul P, Mueller S: Distinct production of autoantibodies to nuclear components in ulcerative colitis and Crohn's disease. Clin Immunol Immunopathol 77:349–357, 1995

    Google Scholar 

  10. Farmer RG: Association of inflammatory bowel disease in families. Front Gastrointest Res 11:235–241, 1986

    Google Scholar 

  11. Fiocchi C, Roche JK, Michener WM: High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. Ann Intern Med 110:786–794, 1989

    Google Scholar 

  12. Czaja AJ, Manns MP: The validity and importance of subtypes in autoimmune hepatitis: A point of view. Am J Gastroenterol 90:1206–1211, 1995

    Google Scholar 

  13. Mohan C, Datta SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209–220, 1995

    Google Scholar 

  14. Godeau P, Piette JC, Frances C, Huong Du LT, Bletry O, Wechsler B: The multiple clinical aspects of lupus. Clin Exp Rheumatol, Suppl 5:27–35, 1990

    Google Scholar 

  15. Brey RL: Antiphospholipid antibodies and stroke. Heart Dis Stroke 1:379–382, 1992

    Google Scholar 

  16. Cameron JS, Frampton G: The antiphospholipid syndrome and the lupus anticoagulant. Pediatr Nephrol 4:663–678, 1990

    Google Scholar 

  17. Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245–251, 1975

    Google Scholar 

  18. Vecchi M, Cattaneo M, de Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21:165–170, 1991

    Google Scholar 

  19. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 3:773–778, 1992

    Google Scholar 

  20. Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, Hudson M, Sawyerr AM, Pounder RE: Early mucosal changes in Crohn's disease. Gut 34:375–381, 1993

    Google Scholar 

  21. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2(8671):1057–1062, 1989

    Google Scholar 

  22. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 108:1011–1015, 1995

    Google Scholar 

  23. Bennet RA, Rubin PH, Present DH: Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 100:1638–1643, 1991

    Google Scholar 

  24. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29:990–996, 1988

    Google Scholar 

  25. Colombel JF, Grandbastien B, Gower-Russeau C, Plegat S, Evrard JP, Dupas JL, Gendre JP, Modigliani R, Belaiche J, Hostein J, Hugot JP, Van Kruiningen H, Cortot A: Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111:604–607, 1996

    Google Scholar 

  26. Bayless TM, Tokayer AZ, Polito JM, Quaskey SA, Mellits ED, Harris LM: Crohn's disease: Concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology 111:573–579, 1996

    Google Scholar 

  27. Polito MJ, Rees CR, Childs B, Mendeloff AI, Harris LM, Bayless TM: Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 347:798–800, 1996

    Google Scholar 

  28. Polito JM, Childs B, Mellits DE, Tokayer AZ, Harris LM, Bayless TM: Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111:580–586, 1996

    Google Scholar 

  29. Peeters M, Nevens H, Baert F, Hiele M, De Meyer AM, Vlietinck R, Ruutgerts P: Familial aggregation in Crohn's disease: Increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111:597–603, 1996

    Google Scholar 

  30. Satsangi J, Grootscholten C, Holt H, Jewell DP: Clinical patterns of familial inflammatory bowel disease. Gut 38:738–741, 1996

    Google Scholar 

  31. Calkins BM, Mendeloff AI: Epidemiology of inflammatory bowel disease. Epidemiol Rev 8:60–91, 1986

    Google Scholar 

  32. Shanahan F, Duerr HR, Rotter IJ, Yang H, Sutherland RL, McElree C, Landers JC, Targan SR: Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity. Gastroenterology 103:456–461, 1992

    Google Scholar 

  33. Seibold F, Slametschka D, Gregor M, Weber P: Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107:532–536, 1994

    Google Scholar 

  34. Reumaux D, Delecourt L, Colombel JF, Noel LH, Duthilleul P, Cortot A: Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis. Gastroenterology 103:1706, 1992 (letter; comment)

    Google Scholar 

  35. Monteleone G, Doldo P, Marasco R, Parello T, Imeneo M, DeMedici A, Giglio A, Luzza F, Pallone F: Perinuclear neutrophil autoantibodies (p-ANCA) in unaffected relatives of patients with ulcerative colitis (UC). Suggestions against familial aggregation. Gut 35(suppl 4):A31, 1994

    Google Scholar 

  36. Lee JC, Lennard-Jones JE, Cambridge G: Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 108:428–433, 1995

    Google Scholar 

  37. Papo M, Quer JC, Pastor MR, Garcia-Pardo G, Prats E, Mirapeix E, Rodriguez R, Richart C: Antineutrophil cytoplasmatic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 91:1512–1515, 1996

    Google Scholar 

  38. Folwaczny C, Noehl N, Endres SP, Heldwein W, Loeschke K, Fricke H: Anti-goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterology (in press)

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Folwaczny, C., Noehl, N., Endres, S. et al. Antinuclear Autoantibodies in Patients with Inflammatory Bowel Disease (High Prevalence in First-Degree Relatives). Dig Dis Sci 42, 1593–1597 (1997). https://doi.org/10.1023/A:1018832608899

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018832608899

Navigation